Balloon or gauze: which stops Post-Birth bleeding better?
NCT ID NCT07609589
First seen Jun 01, 2026 · Last updated Jun 23, 2026 · Updated 5 times
Summary
This study tests two simple methods to control heavy bleeding after childbirth when the uterus fails to contract. About 216 women will be randomly assigned to receive either a balloon placed in the uterus or gauze packing. The goal is to see which stops bleeding within 24 hours without needing more surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Uterine balloon tamponade or uterine gauze packing
What this could lead to
If one method works better, it could give doctors a simple, low-cost way to stop severe bleeding after childbirth and save lives.
What could go wrong
This is a small, early-stage trial with 216 people. Results may not apply to all hospitals, and both methods have risks like infection or failure to stop bleeding.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.